"2025 was a year of meaningful progress for Greenway"

Greenway Greenhouse Cannabis has provided a review of its operational and strategic progress throughout 2025, a year defined by execution, efficiency gains, and the launch of the Company's international wholesale program.

Better operations and lower costs
Greenway improved how it uses its existing greenhouse space, which helped increase crop yields, reduce costs, and make production more predictable. These gains came from better planning, smarter strain choices, and more efficient use of its facilities. The company believes these improvements are long-lasting and will support profitability going forward.

Expansion into international market
Greenway made meaningful progress advancing its international wholesale program throughout 2025, with the Company's cannabis products reaching multiple jurisdictions across Europe as well as Australia in its first full year participating in the international market. This growing international presence reflects both the consistency and quality of Greenway's cultivation output, as well as the Company's ability to meet the regulatory, logistical, and compliance requirements of global medical cannabis markets. The expansion of these international channels occurred alongside continued growth in global medical cannabis demand.

In the United Kingdom, Greenway announced a supply agreement with 4C Labs, establishing a dedicated pathway for sales into the U.K. medical cannabis market. This partnership is distinct from the Company's other international distribution efforts and is focused exclusively on serving the U.K., further complementing Greenway's broader global sales footprint.

The Company expects international wholesale to remain a key area of focus as it continues to build commercial relationships and position itself to supply growing demand across regulated global markets.

Ready for the next stage of growth
Greenway enters its next phase of growth, focusing on bringing existing built-out capacity into production. The Company has previously completed the build-out of this additional space, positioning Greenway to increase output in a measured and demand-driven manner without the need for material incremental capital expenditures, increasing total production capabilities by more than 75%.

As international sales channels continue to develop, management expects the utilization of this existing capacity to support materially higher production volumes, driving top-line revenue growth while preserving the Company's disciplined cost structure. Drawing on its leadership team's deep experience in large-scale commercial agriculture, Greenway believes that scaling into this additional space can be achieved without negatively impacting per-gram production costs, further strengthening operating leverage as volumes increase.

"2025 was a year of meaningful progress for Greenway across several fronts," said Jamie D'Alimonte, Chief Executive Officer of Greenway. "We delivered a 20% increase in total revenue during the calendar year, alongside an improvement in our average selling price per gram of over 40%, reflecting both stronger demand and the quality of our product. At the same time, we remained focused on operational execution and cost discipline, which has helped insulate the business through a challenging market environment.

Looking ahead, the next phase of growth is centered on the utilization of existing cultivation capacity. "The additional cultivation space is already built, and as demand continues to develop across our sales channels, we expect to begin bringing that capacity into production in a deliberate and controlled manner. Based on our experience operating at scale, we believe we can increase output materially without negatively impacting our cost structure, positioning the Company to drive higher revenues and improved profitability as we move forward."